Results 21 to 30 of about 42,495 (262)

The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study

BMC Pulmonary Medicine, 2017
Background N-terminal pro-brain-type natriuretic peptide (NT-proBNP) is currently used as a surrogate marker for disease severity in pulmonary hypertension (PH).
T. M. Berghaus, J. Kutsch, C. Faul, W. von Scheidt, M. Schwaiblmair   +4 more
doaj   +1 more source

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?

Children, 2022
Background/Objective: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a cardiac natriuretic hormone that cardiomyocytes release in response to ventricular stretch.
Ya-Lan Lin, Yi-Li Hung, Chung-Min Shen, Yung-Chuan Chen, Wu-Shiun Hsieh   +4 more
doaj   +1 more source

Reference intervals for N-terminal pro-B-type natriuretic peptide in amniotic fluid between 10 and 34 weeks of gestation. [PDF]

PLoS ONE, 2014
BACKGROUND: In adult and pediatric cardiology, n-terminal pro-B-type natriuretic peptide (nt-proBNP) serves as biomarker in the diagnosis and management of cardiovascular dysfunction.
Waltraut M Merz, Christina Leufgen, Rolf Fimmers, Birgit Stoffel-Wagner, Ulrich Gembruch   +4 more
doaj   +1 more source

Prognostic Value of Admission Peak NT-proBNP Combined with Culprit Plaque Types for Predicting Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study

Journal of Cardiovascular Development and Disease, 2022
Objective: Different culprit plaque phenotypes including plaque rupture (PR) and non-plaque rupture (NPR), and N-Terminal prohormone of brain natriuretic peptide (NT-proBNP) have been reported to influence clinical outcomes in patients with acute ...
Jiannan Li, Runzhen Chen, Jinying Zhou, Ying Wang, Xiaoxiao Zhao, Chen Liu, Peng Zhou, Yi Chen, Li Song, Shaodi Yan, Hongbing Yan, Hanjun Zhao   +11 more
doaj   +1 more source

A Novel N-Terminal Pro-B-Type Natriuretic Peptide Assay in the Early Diagnosis of Acute Heart Failure

JACC: Advances
Background: The performance of the novel NT-pro-B-type natriuretic peptide (NT-proBNP)-Access assay in the early diagnosis of acute heart failure (AHF) is unknown.
Maria Belkin, MD, Desiree Wussler, MD, Pedro Lopez-Ayala, MD, Albina Nowak, MD, Danielle M. Gualandro, MD, Dilbar Sailova, MD, Codruta Popescu, MD, Ivo Strebel, PhD, Marie Niggemann, Ms, Julia Reinhardt, PhD, Gabrielle Huré, MS, Nikola Kozhuharov, MD, Freya Jenkins, MD, Emel Kaplan, PhD, Fabiana Sgueglia, Ms, Zaid Sabti, MD, Laureve Chollet, MD, Katharina Rentsch, PhD, Joanna Gawinecka, MD, Felix Mahfoud, MD, Michael Christ, MD, Angelika Hammerer-Lercher, MD, Tobias Breidthardt, MD, Christian Mueller, MD   +23 more
doaj   +1 more source

Oral Bioinspired Peroxisome‐Engineered Probiotics for Modulating Gut Microbiota Homeostasis and Alleviating Cardiac Chemotherapy Toxicity

Advanced Science, EarlyView.
This study developed an oral bioinspired peroxisome‐engineered probiotic (BPEP) by anchoring lipid‐encapsulated ruthenium nanozymes onto Escherichia coli Nissle 1917, utilizing probiotics to deliver nanozymes to the intestinal barrier for reactive oxygen species/reactive nitrogen species elimination, tight junction restoration, and gut microbiota ...
Shuyu Wang, Xiaowan Fan, Chao Zhang, Shuai Han, Yike Guo, Yuchen Wang, Wei Wang, Junyue Xing, Ying Liu, Wei Jiang, Xiaoying Chen   +10 more
wiley   +1 more source

Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure. [PDF]

PLoS ONE, 2013
BACKGROUND: Metabolic syndrome has been shown to be associated with lower levels of plasma N-terminal pro-B-type natriuretic peptide (Nt-proBNP) in the general population.
Huai-Ren Chang, Jen-Che Hsieh, Bang-Gee Hsu, Ling-Yi Wang, Michael Yu-Chih Chen, Ji-Hung Wang   +5 more
doaj   +1 more source

Leonurine Ameliorates Doxorubicin‐Induced Cardiotoxicity via STING/NF‐κB/NLRP3 Inflammasome Signaling Pathway

Advanced Science, EarlyView.
ABSTRACT Doxorubicin‐induced cardiomyopathy (DIC) remains a dose‐limiting clinical challenge. This study reveals that cardiac vascular endothelial cells (CVECs) act as initial sensors of doxorubicin cardiotoxicity: circulating doxorubicin activates the cGAS‑STING pathway in CVECs, triggering NLRP3 inflammasome‑mediated pyroptosis and release of ...
Wang Jun, Chen Xiaoyang, Xu Jianglin, Yang Zhi, Tao Meijiao, He Jiale, Zhao Jiangfeng, Hei Xuanding, Xu Xuegong, Wang Wei, Li Chun   +10 more
wiley   +1 more source

Molecular Pathways Linking Thyroid Dysfunction, NT-proBNP, and Cardiac Health: A Clinical and Biomarker-based Analysis [PDF]

Indian Journal of Medical Biochemistry
Background: Thyroid hormones play a crucial role in cardiovascular function, influencing heart rate, vascular resistance, and myocardial contractility.
Jayesh Warade, Sunil A Chakole
doaj   +1 more source

NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure. [PDF]

PLoS ONE, 2016
BACKGROUND:The diagnosis of heart failure (HF) is often difficult and underestimated in very elderly comorbid patients, especially when an echocardiographic evaluation is not available or feasible.
Riccardo Sarzani, Francesco Spannella, Federico Giulietti, Massimiliano Fedecostante, Piero Giordano, Pisana Gattafoni, Emma Espinosa, Franco Busco, Gina Piccinini, Paolo Dessì-Fulgheri   +9 more
doaj   +1 more source